Skip to content


Prezista (darunavir) is a small molecule pharmaceutical. Darunavir was first approved as Prezista on 2006-06-23. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections. Prezista's patent is valid until 2026-12-26 (FDA).
Trade Name Prezista
Common Name Darunavir
Indication acquired immunodeficiency syndrome, hiv infections
Drug Class Antivirals: HIV protease inhibitors (saquinavir type)
Get full access now